|
Important Safety Information
CAVERJECT IMPULSE is used to treat erection problems
in adult men. It is given by injection into the side
of the penis.
CAVERJECT IMPULSE is not for all men. It is not for
those who have been advised not to have sex. It is
not for men who have penis implants. CAVERJECT
IMPULSE should not be used by men with medical
problems that can cause long-lasting erections—4
hours or more. Priapism requires immediate medical
attention because permanent damage to the tissue of
the penis and loss of potency may result. Tell your
doctor about all of your medical conditions before
using this drug.
Call your doctor at once if you still have an
erection 4 hours after injection. This is dangerous.
You must get medical attention right away.
The most common side effect of CAVERJECT IMPULSE is
mild to moderate pain after injection. About one
third of patients reported this pain but few stopped
CAVERJECT IMPULSE for this reason.
Men may get a small amount of bleeding at the
injection site. Call your doctor if you notice any
redness, lumps, swelling, tenderness, or curving of
the erect penis. Lumps or curving of the erect penis,
including a condition called Peyronie's disease, were
reported in clinical trials with CAVERJECT IMPULSE.
CAVERJECT IMPULSE should not be used more than 3
times per week. There must be at least 24 hours (1
day) between each dose. It should produce an erection
in about 5 to 20 minutes that should last about 1
hour. You must be taught by your doctor how to inject
before using this drug.
Do not share needles or syringes. Put used needles
and syringes in a safe container before throwing
away. Protect others from getting stuck by the
needle.
The health information contained herein is provided
for educational purposes only and is not intended to
replace discussions with a healthcare provider. All
decisions regarding patient care must be made with a
healthcare provider, considering the unique
characteristics of the patient.
The product information provided in this site is
intended only for residents of the United States. The
products discussed herein may have different product
labeling in different countries.
|
© 2005-2006 Pfizer Inc. All rights reserved.
|
|